TNGX vs TYL · $5.36B cap vs P/E 89, rev $1.26B
Tango Therapeutics Inc (TNGX) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Tango Therapeutics Inc (TNGX) is a biotechnology company listed on NASDAQ.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported TNGX revenue for 2026-06-30 was $0. Net income was -$100.9M. TNGX currently screens at market cap $5.36B.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
TNGX currently screens at market cap $5.36B. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the TNGX and TYL stock pages for the full models.
Not investment advice.